Press releaseGlobe Newswire
TAP Real Estate Technologies
RWAX · Other
$0.0002+$0.00 (+0.00%)TodayMarket closed ·
Prev close $0.0002
RWAX key statistics
- Market cap
- —
- Price-earnings ratio
- —
- Dividend yield
- —
- Average volume
- 51.86M
- Volume
- 146.65M
- Open price
- $0.0002
- High today
- $0.0002
- Low today
- $0.00
- 52 Week high
- $0.0005
- 52 Week low
- $0.00
TAP Real Estate Technologies (RWAX) at a glance
As of Oct 30, 2026, TAP Real Estate Technologies (RWAX) shares are priced at $0.0002.
Today the stock has traded between $0.00 and $0.0002. The current price is 19900.0% above the day's low and 0.0% below its high.
Volume so far is 146.65M shares, above the average of 51.86M shares a day.
Over the past year TAP Real Estate Technologies has ranged from $0.00 to $0.0005, and now sits 40% of the way up that range.
RWAX news
Most active stocks
Highest trading volume today
- BURUNuburu$0.287−22.79%
- INTCIntel$65.76−28.58%
- SLGBSmart Logistics Global$0.3051+48.97%
- AXXAExxe Group$0.0006+50.00%
- RDARRaadr$0.0002+0.00%
- SOXLDirexion Shares ETF Trust$77.05−24.75%
- HUBCHub Cyber Security$0.1134−16.00%
- NVDANVIDIA$204.64−4.20%
- NVDGraniteShares ETF Trust$4.43+8.19%
- SPCXSpace Exploration Technologies$134.69−6.39%
- GTVHGolden Triangle Ventures$0.0001+0.00%
Newly listed
Companies that went public in the past six weeks
- GBCGEORGIA BANKING$38.38+0.27%
- BHAIUBHAV Acquisition Corp II$9.98+0.00%
- SCQCUSPACCircle Acquisition$9.99+0.05%
- LYCALycia Therapeutics$26.40−4.80%
- DAVIDAVION HEALTHCARE$1.68−37.55%
- TCXBTCGX Acquisition Corp. II$10.14−0.66%
- CTYCITY THERAPEUTICS$20.71−6.46%
- IAMIambic Therapeutics$13.43−5.95%
- AMROAmaero$5.56−3.81%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.17−0.39%
- TRXBTRex Bio$13.74+1.63%
- RTSNRetension Pharmaceuticals$11.36−3.97%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.